Sciclone Pharma (SCLN) Income Statement

Click line-items for a historical chart and %

Revenues:
Product sales	39.46M
Promotion services	1.09M
Total revenues	40.54M
Operating expenses:
Cost of product sales
Sales and marketing	13.32M
Amortization of acquired intangible assets, related to sales and marketing
Research and development	3.29M
General and administrative	7.9M
Contingent consideration
Total operating expenses
Income from operations	10.45M
Non-operating income (expense):
Interest and investment income	270K
Interest and investment expense
Other (expense) income, net	451K
Income before provision for income tax
Provision for income tax	1.06M
Net income	10.12M
Basic net income per share	0.2
Diluted net income per share	0.19

Entities mentioned with SCLN